Company to Offer Practitioners Point-of-Care Hemoglobin Analyzer for
Fast Delivery of Blood Test Results
MELVILLE, N.Y.--(BUSINESS WIRE)--Apr. 24, 2019--
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc.
(Nasdaq: HSIC), announced today its new private label-branded product,
OneStep™ + Pro Hb Analyzer, a portable, reagent-free hemoglobin
analyzer, which measures hemoglobin concentration as a result of a
fingerstick blood test. Distributed in the United States, the analyzer
can quickly determine low or high levels of hemoglobin, making it
possible for practitioners to determine why a patient may be fatigued or
not feeling well.
“We have been working diligently to expand our private label portfolio
with cost-effective, high-quality solutions our customers can rely on to
meet their practice and patient needs,” said Brad Connett, President,
U.S. Medical Group, Henry Schein. “With the addition of OneStep + Pro Hb
Analyzer, customers at physicians’ offices, clinics and other
non-traditional laboratory locations can deliver quick and convenient
tests thanks to a premier analyzer with reliable, laboratory-quality
The OneStep + Pro Hb Analyzer provides clinicians at Physician Office
Labs, Family/Internal Medicine clinics, OB/GYN Centers, Pediatric
clinics, Planned Parenthoods, Community Health Centers and Urgent Cares
with accurate hemoglobin and hematocrit measurements within
three seconds of collecting a blood sample in a cuvette - a
straight-sided, optically clear container for holding liquid samples -
and inserting into the analyzer. This helps ensure fast results for
patient health checks and anemia screening at the point-of-care setting.
For more information, please visit www.henryschein.com/onestep+prohb
or call 1-800-772-4346 to speak with a Henry Schein Medical sales
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care
professionals powered by a network of people and technology. With more
than 18,000 Team Schein
Members worldwide, the Company's network of trusted advisors
provides more than 1 million customers globally with more than 300
valued solutions that improve operational success and clinical outcomes.
Our Business, Clinical, Technology, and Supply Chain solutions help
office-based dental and medical practitioners
work more efficiently so they can provide quality care more effectively.
These solutions also support dental
and institutional health care clinics, as well as other alternate
Henry Schein operates through a centralized and automated distribution
network, with a selection of more than 120,000 branded products and
Henry Schein private-brand products in stock, as well as more than
180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® and the Nasdaq 100®
indexes, Henry Schein is headquartered in Melville, N.Y., and has
operations or affiliates in 31 countries. The Company's sales from
continuing operations reached $9.4 billion in 2018, and have grown at a
compound annual rate of approximately 13 percent since Henry Schein
became a public company in 1995.
For more information, visit Henry Schein at www.henryschein.com,
View source version on businesswire.com: https://www.businesswire.com/news/home/20190424005347/en/
Source: Henry Schein, Inc.
Media: Ann Marie Gothard
Vice President, Corporate Media Relations